JAX APML integrates the latest sequencing technologies with the insights of an experienced multidisciplinary team of scientists to help clinicians and translational researchers select the best options for personalized care.
JAX APML integrates the latest sequencing technologies with the insights of an experienced multidisciplinary team of scientists to help clinicians and translational researchers select the best options for personalized care.
The JAX Advanced Precision Medicine Laboratory delivers precise genomic testing and critical data analysis services to help improve patient care. The CLIA-certified, CAP-accredited, and NCI-MATCH-designated laboratory features the latest sequencing and PCR technologies. The experienced, multidisciplinary team of scientists uses comprehensive knowledgebases to help oncologists and translational researchers identify relevant biomarkers, interpret complex genomic tumor profiles, and select the best treatment options for each patient. The laboratory provides comprehensive molecular profiling services for all solid tumors, with specialized resources for those found in the brain and central nervous system. JAX APML offers the following advantages in terms of clinical service:
ExpertiseCollaborate with a world-renowned laboratory with more than 80 years of genetic discovery experience
Accuracy
Gain insights from powerful machine learning algorithms and a sophisticated clinical knowledgebase to generate precise, evidence-driven results
Customer Experience
Ability to tailor services based on specific timeline requirements
Validated Performance
During clinical validation, 98% of samples with reportable calibration scores were found to confirm, refine, or correct the original pathological diagnosis
Speed
Receive results within a clinically actionable time frame to accelerate treatment decisions
The JAX APML has accomplished an impressive number of milestones in a very short time, demonstrating the scientific excellence required to earn the trust of several credentialing groups and laying the foundation for the application of the faculty's genomic discoveries to direct patient care.
| Licenses & Accreditations | Number | Expiration Date |
| College of American Pathologists (CAP) Accreditation | CAP: 8737269; AU-ID: 1693018 | June 20, 2028 |
| Clinical Laboratory Improvement Amendments (CLIA) Accreditation | 07D2061461 | September 16, 2026 |
| State of California License | CDS 00800512 | December 12, 2026 |
| State of Connecticut License | CL-0695 | September 30, 2027 |
| State of Maryland License | 2389 | No Expiration |
| State of Pennsylvania License | 34700 | August 15, 2026 |
| State of Rhode Island License | LCO00986 | December 30, 2027 |
The JAX APML provides clinical laboratory services in accordance with CLIA and CAP regulatory requirements. Assay selection and interpretation is consistent with the guidelines of relevant medical professional societies, including:
This notice describes how medical information about you may be used and disclosed, and how you can get access to this information. Please review it carefully.
The Jackson Laboratory accepts institutional billing and self-pay. Any questions regarding billing or to have a Statement of Work established, please reach out to our Customer Support Team at [email protected] or 1.860.837.2320. We accept checks, credit cards (except Discover), ACH, and wire transfer.